相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetes mellitus and melatonin: Where are we?
Roma Patel et al.
BIOCHIMIE (2022)
Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice
Swati Prakash et al.
BIOCHIMIE (2020)
Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α and irisin in a rat model of type 2 diabetes mellitus
Yuntao Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Genetic variants of tumor necrosis factor-α and its levels: A correlation with dyslipidemia and type 2 diabetes susceptibility
Roma Patel et al.
CLINICAL NUTRITION (2019)
Melatonin in type 2 diabetes mellitus and obesity
Angeliki Karamitri et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Association of melatonin & MTNR1B variants with type 2 diabetes in Gujarat population
Roma Patel et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity
Sharon Owino et al.
JOURNAL OF PINEAL RESEARCH (2018)
Combined treatment with melatonin and insulin improves glycemic control, white adipose tissue metabolism and reproductive axis of diabetic male rats
Ariclecio Cunha de Oliveira et al.
LIFE SCIENCES (2018)
DPP-4 Inhibitor Sitagliptin Improves Cardiac Function and Glucose Homeostasis and Ameliorates β-Cell Dysfunction Together with Reducing S6K1 Activation and IRS-1 and IRS-2 Degradation in Obesity Female Mice
Shigang Qiao et al.
JOURNAL OF DIABETES RESEARCH (2018)
Melatonin receptors: molecular pharmacology and signalling in the context of system bias
Erika Cecon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Effects of metformin and sitagliptin on glycolipid metabolism in type 2 diabetic rats on different diets
Juhong Yang et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
Pioglitazone increases PGC1-α signaling within chronically ischemic myocardium
Tammy A. Butterick et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes
Tiinamaija Tuomi et al.
CELL METABOLISM (2016)
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study
Hiroshi Sakura et al.
BMC ENDOCRINE DISORDERS (2016)
High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice
Roel A. van der Heijden et al.
AGING-US (2015)
Activation of Melatonin Signaling Promotes β-Cell Survival and Function
Safia Costes et al.
MOLECULAR ENDOCRINOLOGY (2015)
Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor
Felicia Goldsmith et al.
PLOS ONE (2015)
Overnutrition, mTOR signaling, and cardiovascular diseases
Guanghong Jia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
Improved glucose tolerance with restored expression of glucose transporter 4 in C57BL/6 mice after a long period of high-fat diet feeding
Jinil Kim et al.
ANIMAL CELLS AND SYSTEMS (2014)
Melatonin, energy metabolism, and obesity: a review
J. Cipolla-Neto et al.
JOURNAL OF PINEAL RESEARCH (2014)
Acute Melatonin Administration in Humans Impairs Glucose Tolerance in Both the Morning and Evening
Patricia Rubio-Sastre et al.
SLEEP (2014)
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats
Nattayaporn Apaijai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Moderate GLUT4 Overexpression Improves Insulin Sensitivity and Fasting Triglyceridemia in High-Fat Diet-Fed Transgenic Mice
Brittanie J. Atkinson et al.
DIABETES (2013)
Chronotype Is Independently Associated With Glycemic Control in Type 2 Diabetes
Sirimon Reutrakul et al.
DIABETES CARE (2013)
Melatonin and Pancreatic Islets: Interrelationships between Melatonin, Insulin and Glucagon
Elmar Peschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Minireview: Toward the Establishment of a Link between Melatonin and Glucose Homeostasis: Association of Melatonin MT2 Receptor Variants with Type 2 Diabetes
Angeliki Karamitri et al.
MOLECULAR ENDOCRINOLOGY (2013)
Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
Selvihan Beysel Akaslan et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2013)
Acute and sustained inflammation and metabolic dysfunction induced by high refined carbohydrate-containing diet in mice
Marina C. Oliveira et al.
Obesity (2013)
Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance
Elaine Xu et al.
DIABETES (2012)
Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes
S. M. Poucher et al.
DIABETES OBESITY & METABOLISM (2012)
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
K. D. Copps et al.
DIABETOLOGIA (2012)
Novel Biological Action of the Dipeptidylpeptidase-IV Inhibitor, Sitagliptin, as a Glucagon-Like Peptide-1 Secretagogue
Ganesh V. Sangle et al.
ENDOCRINOLOGY (2012)
Sitagliptin Reduces Hyperglycemia and Increases Satiety Hormone Secretion More Effectively When Used with a Novel Polysaccharide in Obese Zucker Rats
Raylene A. Reimer et al.
JOURNAL OF NUTRITION (2012)
Melatonin influences insulin secretion primarily via MT1 receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets
Eckhard Muehlbauer et al.
JOURNAL OF PINEAL RESEARCH (2012)
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
A. D. Dobrian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Both sitagliptin analogue & pioglitazone preserve the β-cell proportion in the islets with different mechanism in non-obese and obese diabetic mice
Jin-A Yeom et al.
BMB REPORTS (2011)
Absence of Melatonin Induces Night-Time Hepatic Insulin Resistance and Increased Gluconeogenesis Due to Stimulation of Nocturnal Unfolded Protein Response
Tatiane C. Nogueira et al.
ENDOCRINOLOGY (2011)
Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance
Joan Vendrell et al.
ENDOCRINOLOGY (2011)
Evidence for a Gut-Brain Axis Used by Glucagon-like Peptide-1 to Elicit Hyperglycaemia in Fish
S. Polakof et al.
JOURNAL OF NEUROENDOCRINOLOGY (2011)
Melatonin as a natural ally against oxidative stress: a physicochemical examination
Annia Galano et al.
JOURNAL OF PINEAL RESEARCH (2011)
New evidence for a role of melatonin in glucose regulation
Elmar Peschke et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
Vanessa Souza-Mello et al.
CLINICAL SCIENCE (2010)
Current views on type 2 diabetes
Yi Lin et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats
Maria J. Rios-Lugo et al.
JOURNAL OF PINEAL RESEARCH (2010)
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Richard M. Bergenstal et al.
LANCET (2010)
Melatonin Improves Glucose Homeostasis and Endothelial Vascular Function in High-Fat Diet-Fed Insulin-Resistant Mice
Claudio Sartori et al.
ENDOCRINOLOGY (2009)
Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes
James Mu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCζ-Akt-GSK3β pathway in hepatic cells
Jiunn-Min Shieh et al.
JOURNAL OF PINEAL RESEARCH (2009)
Variants in MTNR1B influence fasting glucose levels
Inga Prokopenko et al.
NATURE GENETICS (2009)
A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
Nabila Bouatia-Naji et al.
NATURE GENETICS (2009)
Adverse metabolic and cardiovascular consequences of circadian misalignment
Frank A. J. L. Scheer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of melatonin in metabolic regulation
Ahmet Korkmaz et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
Itamar Raz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Function and expression of melatonin receptors on human pancreatic islets
Reshma D. Ramraeheya et al.
JOURNAL OF PINEAL RESEARCH (2008)
Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic β-cells
Ina Stumpf et al.
JOURNAL OF PINEAL RESEARCH (2008)
Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat-fed mice
Benjamin J. Lamont et al.
DIABETES (2008)
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes
Gary A. Herman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1
Brian D. Green et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats
Min Pan et al.
JOURNAL OF PINEAL RESEARCH (2006)
Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells
Eunyoung Ha et al.
JOURNAL OF PINEAL RESEARCH (2006)
Depression of glucose levels and partial restoration of pancreatic β-cell damage by melatonin in streptozotocin-induced diabetic rats
Mehmet Kanter et al.
ARCHIVES OF TOXICOLOGY (2006)
Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status
E Peschke et al.
JOURNAL OF PINEAL RESEARCH (2006)
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B
L Li et al.
DIABETOLOGIA (2005)
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
J Buteau et al.
DIABETOLOGIA (2004)
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial
K Esposito et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats
S Nishida et al.
JOURNAL OF PINEAL RESEARCH (2003)
Identification and functional characterization of inelatonin Mel 1a receptors in pancreatic β cells:: potential role in incretin-mediated cell function by sensitization of cAMP signaling
DM Kemp et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity
S Nishida et al.
JOURNAL OF PINEAL RESEARCH (2002)
Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women
A Cagnacci et al.
CLINICAL ENDOCRINOLOGY (2001)
Effect of GLP-1 on lipid metabolism in human adipocytes
ML Villanueva-Peñacarrillo et al.
HORMONE AND METABOLIC RESEARCH (2001)
分享论文
